Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19
Status:
Recruiting
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
A randomized clinical trial designed and intended to evaluate the efficacy of Dexamethasone
and Methylprednisolone as a treatment for severe Acute Respiratory Distress Syndrome (ARDS)
caused by coronavirus disease 19 (COVID-19). Our aim is to find the best option for the
treatment and management of ARDS in COVID-19 patients.
Phase:
Phase 3
Details
Lead Sponsor:
Chattogram General Hospital
Collaborators:
Health Science Center of Xi'an Jiaotong University Health Science Center of Xi’an Jiaotong University